英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
merus查看 merus 在百度字典中的解释百度英翻中〔查看〕
merus查看 merus 在Google字典中的解释Google英翻中〔查看〕
merus查看 merus 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • MerusCase - Technology for Attorneys
    MerusCase intuitively adapts to fit your practice — streamlining document automation, time tracking, billing, calendaring, email, and case management into one easy-to-use system that's accessible anywhere, anytime, from any device
  • Pipeline - Merus
    Our strategy employs the unique attributes of our proprietary bispecific antibodies and our patented screening technologies to engage and harness the power of the immune system to target tumor cells
  • Merus - Dragon Ball Wiki
    Merus Ikanoichiyabosshi (メルス・イカノイチヤボッシ, Merusu Ikanoichiyabosshi), formerly just Merus (メルス, Merusu), is the number one elite patrolman of the Galactic Patrol and formerly a Trainee Angel
  • Merus | Design-Build Developer, 100% Employee-Owned
    Employee-owned, culture-obsessed and career-oriented, Merus is a place where we all grow and succeed together Formerly known as Al Neyer, Merus combines more than 130 years of commercial real estate expertise with an integrated team of company owners
  • Merus N. V. (MRUS) Stock Price, News, Quote History - Yahoo . . .
    Find the latest Merus N V (MRUS) stock quote, history, news and other vital information to help you with your stock trading and investing
  • Merus hails unprecedented survival on solid tumor . . .
    Merus has reported a 79% 12-month survival rate in cancer patients on its bispecific antibody, cementing William Blair analysts' belief the candidate has a “best-in-disease profile ”
  • Merus’ Bispecific Shows ‘Best in Disease’ Profile in Head-and . . .
    Merus’ investigational bispecific antibody petosemtamab, when combined with Merck’s mega-blockbuster Keytruda, led to a nearly 80% overall survival rate when used as a frontline treatment option for certain patients with head and neck cancer, according to a Phase II readout posted Thursday
  • MerusCase
    © 2008-2023 Merus, Inc Merus™, MerusCase™, and the MerusCase Logo are registered trademarks of Merus, Inc All rights reserved
  • Merus Stock Skyrockets On Unprecedented Results In Head-And . . .
    Merus stock rocketed to a six-month high — and hammered shares of rival Bicara Therapeutics — after unveiling promising new results for its experimental head-and-neck cancer treatment
  • Closing in on cancer | Merus
    At Merus, we know that time is of the essence Every day, we bring a sense of urgency and a passion to help patients, by working towards discovering and developing new treatments for cancer





中文字典-英文字典  2005-2009